Intelligence Β· Clinical Pipeline

Agios Netherlands Pipeline

All ClinicalTrials.gov programs at Agios Netherlands β€” phase, modality, and trial IDs.

Programs
29

Quick answer

Agios Netherlands has 29 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. AG-120 (Ivosidenib)

    Agios Netherlands B.V.

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial
  2. AG-181

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  3. AG-181

    Agios Netherlands B.V.

    Phenylketonuria

    phase 1 small molecule active

    1 trial
  4. AG-236

    Agios Netherlands B.V.

    Healthy Participants

    phase 1 small molecule active

    1 trial
  5. AG-348

    Agios Netherlands B.V.

    Healthy

    phase 1 small molecule completed

    1 trial
  6. AG-348

    Agios Netherlands B.V.

    Sickle Cell Disease

    phase 1 small molecule completed

    1 trial
  7. AG-348

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  8. AG-348

    Agios Netherlands B.V.

    Healthy Volunteer

    phase 1 small molecule completed

    2 trials
  9. AG-348 Sequence A

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  10. AG-519

    Agios Netherlands B.V.

    Anemia

    phase 1 small molecule terminated

    1 trial
  11. AG-636

    Agios Netherlands B.V.

    Lymphoma

    phase 1 small molecule terminated

    1 trial
  12. AG-881

    Agios Netherlands B.V.

    Healthy Male Participants

    phase 1 small molecule completed

    1 trial
  13. AG-881

    Agios Netherlands B.V.

    Healthy Participants

    phase 1 small molecule completed

    1 trial
  14. AG-946

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  15. AG120

    Agios Netherlands B.V.

    Healthy

    phase 1 small molecule completed

    2 trials
  16. AG221

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  17. AG881

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  18. AG881

    Agios Netherlands B.V.

    Acute Myeloid Leukemia (AML)

    phase 1 small molecule completed

    1 trial
  19. AG881 Formulation 1

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  20. Ivosidenib

    Agios Netherlands B.V.

    IDH1 Mutation Myeloid Neoplasms

    phase 1 small molecule completed

    1 trial
  21. Mitapivat

    Agios Netherlands B.V.

    Healthy Participants

    phase 1 small molecule completed

    1 trial
  22. Mitapivat

    Agios Netherlands B.V.

    Moderate Hepatic Impairment

    phase 1 small molecule completed

    1 trial
  23. Mitapivat tablet

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  24. Mitapivat tablets

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  25. Placebo for Treatment A

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  26. [14C]-AG-120

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  27. [14C]-tebapivat

    Agios Netherlands B.V.

    Healthy Participants

    phase 1 small molecule completed

    1 trial
  28. itraconazole

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  29. ivosidenib (AG-120)

    Agios Netherlands B.V.

    Healthy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does Agios Netherlands have?

29 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs